Biotech & MedTech
-
Greg Fenton Discusses ZenGUARD™ Antimicrobial Coating and Military Interest in Zentek’s Aptamer Technology
May 16, 2024 — In a recent interview with InvestorNews host Pat Bolland, Greg Fenton, CEO and Director of…
-
InvestorTalk Alert: Greg Fenton from Zentek Ltd. to host on Wednesday, May 15, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Wednesday, May 15th, at 9 AM EST,…
-
Coeptis Therapeutics’ Dave Mehalick on Making Cell Therapy Universally Accessible
April 30, 2024 — In a recent interview with InvestorNews, Dave Mehalick, Chairman, President, and CEO of Coeptis…
-
André Larente from DIAGNOS on Transforming Optometry and Expanding AI Capabilities
April 29, 2024 — In a recent interview with InvestorNews host Tracy Weslosky, André Larente, President, CEO, and…
-
Dave Mehalick from Coeptis Therapeutics to Host InvestorTalk (04.25.2024)
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for Thursday, April 25th at 9 AM EST, featuring…
-
Andre Larente from DIAGNOS to Host InvestorTalk (04.24.2024)
InvestorNews is hosting an InvestorTalk this morning with André Larente, CEO, President, and Director from DIAGNOS Inc. (TSXV:…
-
FendX Technologies’ Dr Carolyn Myers Provides REPELWRAP Film Manufacturing Dunmore Partnership Update
In a recent interview with Tracy Weslosky, Dr. Carolyn Myers, President, CEO, and Director of FendX Technologies Inc.…
-
Coeptis Therapeutics’ Dave Mehalick on the disruptive potential of SNAP-CAR technology for autoimmune diseases
In an insightful interview with Tracy Weslosky, Dave Mehalick, Chairman, President, and CEO of Coeptis Therapeutics Holdings, Inc.…
-
Greg Fenton Discusses Zentek’s 2024 Progress and Exclusive Aptamer Technology Rights
In a detailed interview with Tracy Weslosky, Greg Fenton, CEO and Director of Zentek Ltd. (NASDAQ: ZTEK |…
